Skip to main content
. 2019 Jul-Sep;6(3):277–282. doi: 10.4103/apjon.apjon_4_19

Table 2.

Patient disposition

Participants No. (%)
Included in the study 220 (100)
Analyzed for effectiveness 200 (91)
Discontinued for other reasons than alopecia 20 (9)
 Low tolerability 4
 Side effects 16